Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection
Authors:
Open Access
- 5 July 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-15
Abstract
Neisseria meningitidis(meningococcus) causes invasive diseases such as meningitis or septicaemia.Ex vivoinfection of human whole blood is a valuable tool to study meningococcal virulence factors and the host innate immune responses. In order to consider effects of cellular mediators, the coagulation cascade must be inhibited to avoid clotting. There is considerable variation in the anticoagulants used among studies ofN.meningitidiswhole blood infections, featuring citrate, heparin or derivatives of hirudin, a polypeptide from leech saliva. Here, we compare the influence of these three different anticoagulants, and additionally Mg/EGTA, on host innate immune responses as well as on viability ofN.meningitidisstrains isolated from healthy carriers and disease cases, reflecting different sequence types and capsule phenotypes. We found that the anticoagulants significantly impact on cellular responses and, strain-dependently, also on bacterial survival. Hirudin does not inhibit complement and is therefore superior over the other anticoagulants; indeed hirudin-plasma most closely reflects the characteristics of serum duringN.meningitidisinfection. We further demonstrate the impact of heparin on complement activation onN.meningitidisand its consequences on meningococcal survival in immune sera, which appears to be independent of the heparin binding antigens Opc and NHBA.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (JO 1204/2-1)
This publication has 60 references indexed in Scilit:
- In Vivo Adaptation and Persistence of Neisseria meningitidis within the Nasopharyngeal MucosaPLOS Pathogens, 2013
- Analysis of the Regulated Transcriptome of Neisseria meningitidis in Human Blood Using a Tiling ArrayJournal of Bacteriology, 2012
- Direct thrombin inhibitorsBritish Journal of Clinical Pharmacology, 2011
- Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood SurvivalPLOS Pathogens, 2011
- Virulence Evolution of the Human Pathogen Neisseria meningitidis by Recombination in the Core and Accessory GenomePLOS ONE, 2011
- The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to ComplementPLOS Pathogens, 2010
- An Evaluation of the Role of Properdin in Alternative Pathway Activation on Neisseria meningitidis and Neisseria gonorrhoeaeThe Journal of Immunology, 2010
- Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansProceedings of the National Academy of Sciences, 2010
- Stages of Meningococcal Sepsis Simulated In Vitro, with Emphasis on Complement and Toll-Like Receptor ActivationInfection and Immunity, 2008
- Transgenic Mice Expressing Human Transferrin as a Model for Meningococcal InfectionInfection and Immunity, 2007